Phentermine / Topiramate Oral Product for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 9 Nov 2020: Trial registered, NCT04621929
  2. 31 Mar 2021: Trial started, NCT04621929

The trials

NCT04621929: Phentermine/Topiramate for Uric Acid Stones

State
Completed
Phase
Phase 2
People
19 taking part
Started
31 Mar 2021
Primary completion
14 Nov 2024
Arms
Allocated to intervention/treatment
Results
Posted on the registry
  1. 9 Nov 2020: Trial registered
  2. 31 Mar 2021: Trial started
  3. 14 Nov 2024: Trial completed
  4. 30 Jan 2026: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.